Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03682575 · ClinicalTrials.gov registry record
Work of Breathing in Premature Infants at Discharge
A clinical trial, sponsored by Christiana Care Health Services.
- Completed
- Registry status
- 78
- Enrollment target
NCT03682575: Completed study, sponsored by Christiana Care Health Services.
NCT03682575 is a clinical trial that has completed, run by Christiana Care Health Services. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03682575 has completed, sponsored by Christiana Care Health Services.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
The purpose of this study is to compare how premature infants who required oxygen for at least 28 days during their time in the NICU (Neonatal Intensive Care Unit) breathe at discharge compared to premature infants who did not require oxygen for at least 28 days during their time in the NICU.
Primary Outcome
Respiratory Inductance Plethysmography (RIP) measurements will be taken and Phase Angle will be measured.
Interventions
- OTHER Enrollment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2020-11-10 |
| Est. Completion | 2023-02-28 |
What the finished NCT03682575 record still lists
NCT03682575 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Enrollment is the first listed.
NCT03682575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03682575 about?
NCT03682575 is a clinical study titled "Work of Breathing in Premature Infants at Discharge". The purpose of this study is to compare how premature infants who required oxygen for at least 28 days during their time in the NICU (Neonatal Intensive Care Unit) breathe at discharge compared to premature infants who did not require oxygen for at least 28 days during their time in the NICU.
What is the current status of trial NCT03682575?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2020-11-10. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT03682575?
The interventions under investigation include: Enrollment (OTHER).
Who is sponsoring clinical trial NCT03682575?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI